Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 101; no. 3; pp. e95 - e99
Main Authors van der Linden, Marieke H, Boer, Judith M, Schneider, Pauline, Willekes, Merel, Seslija, Lidija, De Lorenzo, Paola, Valsecchi, Maria Grazia, Cazzaniga, Giovanni, Biondi, Andrea, den Boer, Monique L, Pieters, Rob, Stam, Ronald W
Format Journal Article
LanguageEnglish
Published Italy Ferrata Storti Foundation 01.03.2016
Subjects
Antineoplastic Agents, Hormonal - therapeutic use
B-Lymphocytes - drug effects
B-Lymphocytes - metabolism
B-Lymphocytes - pathology
Comparative Genomic Hybridization
DNA Copy Number Variations
Female
Gene Expression Profiling
Gene Expression Regulation, Leukemic
Homeodomain Proteins - genetics
Homeodomain Proteins - metabolism
Humans
Immunophenotyping
Infant
Infant, Newborn
Male
Mutation
Myeloid Ecotropic Viral Integration Site 1 Protein
Neoplasm Proteins - genetics
Neoplasm Proteins - metabolism
Online Only
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality
Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology
Prednisone - therapeutic use
Survival Analysis
Treatment Outcome
infant
ALL
wild-type MLL
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0390-6078
1592-8721
DOI:10.3324/haematol.2014.122119